Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Insulin resistance, metabolic stress, and atherosclerosis.

Pansuria M, Xi H, Li L, Yang XF, Wang H.

Front Biosci (Schol Ed). 2012 Jan 1;4:916-31. Review.

PMID:
22202099
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Insulin resistance, hyperglycemia, and atherosclerosis.

Bornfeldt KE, Tabas I.

Cell Metab. 2011 Nov 2;14(5):575-85. doi: 10.1016/j.cmet.2011.07.015. Review.

PMID:
22055501
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Insulin resistance and atherosclerosis.

Nigro J, Osman N, Dart AM, Little PJ.

Endocr Rev. 2006 May;27(3):242-59. Epub 2006 Feb 21. Review.

PMID:
16492903
[PubMed - indexed for MEDLINE]
4.

Insulin resistance and the endothelium.

QuiƱones MJ, Nicholas SB, Lyon CJ.

Curr Diab Rep. 2005 Aug;5(4):246-53. Review.

PMID:
16033673
[PubMed - indexed for MEDLINE]
5.

Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease.

Rask-Madsen C, Kahn CR.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2052-9. doi: 10.1161/ATVBAHA.111.241919. Review.

PMID:
22895666
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity.

Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW.

Cell Tissue Res. 2009 Jan;335(1):165-89. doi: 10.1007/s00441-008-0685-6. Epub 2008 Oct 22. Review.

PMID:
18941783
[PubMed - indexed for MEDLINE]
7.

Role of insulin resistance and hyperglycemia in the development of atherosclerosis.

Bansilal S, Farkouh ME, Fuster V.

Am J Cardiol. 2007 Feb 19;99(4A):6B-14B. Epub 2006 Dec 20. Review.

PMID:
17307054
[PubMed - indexed for MEDLINE]
8.

[The metabolic syndrome. Part II: its mechanisms of development and its complications].

Pacholczyk M, Ferenc T, Kowalski J.

Postepy Hig Med Dosw (Online). 2008 Oct 16;62:543-58. Review. Polish.

PMID:
18936730
[PubMed - indexed for MEDLINE]
Free Article
9.

Effects of insulin on the vasculature.

Breen DM, Giacca A.

Curr Vasc Pharmacol. 2011 May;9(3):321-32. Review.

PMID:
20807190
[PubMed - indexed for MEDLINE]
10.

Pericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes.

Hayden MR, Yang Y, Habibi J, Bagree SV, Sowers JR.

Oxid Med Cell Longev. 2010 Sep-Oct;3(5):290-303. Epub 2010 Sep 1. Review.

PMID:
21150342
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C, Stas S, Sowers JR.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2009-23. Epub 2007 Jun 22. Review.

PMID:
17586614
[PubMed - indexed for MEDLINE]
Free Article
12.

Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?

Bender SB, McGraw AP, Jaffe IZ, Sowers JR.

Diabetes. 2013 Feb;62(2):313-9. doi: 10.2337/db12-0905. Review.

PMID:
23349535
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia.

Kohen-Avramoglu R, Theriault A, Adeli K.

Clin Biochem. 2003 Sep;36(6):413-20. Review.

PMID:
12951167
[PubMed - indexed for MEDLINE]
14.

[Optimization of animal model for investigation of pathogenesis of type 2 diabetes].

Rushchak VV, Kovalenko VM, Voronina AK, Kitam VO, Maksymchuk OV, Chashchyn MO.

Fiziol Zh. 2012;58(6):29-35. Ukrainian.

PMID:
23530411
[PubMed - indexed for MEDLINE]
15.

Endothelial dysfunction in metabolic and vascular disorders.

Polovina MM, Potpara TS.

Postgrad Med. 2014 Mar;126(2):38-53. doi: 10.3810/pgm.2014.03.2739. Review.

PMID:
24685967
[PubMed - indexed for MEDLINE]
16.

Endothelial dysfunction in diabetes mellitus.

Hadi HA, Suwaidi JA.

Vasc Health Risk Manag. 2007;3(6):853-76. Review.

PMID:
18200806
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome.

Venkatapuram S, Shannon RP.

Am J Ther. 2006 Jan-Feb;13(1):64-71. Review.

PMID:
16428924
[PubMed - indexed for MEDLINE]
18.

Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications.

Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR.

Curr Mol Med. 2006 Aug;6(5):501-14. Review.

PMID:
16918371
[PubMed - indexed for MEDLINE]
19.

Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders.

Song R, Peng W, Zhang Y, Lv F, Wu HK, Guo J, Cao Y, Pi Y, Zhang X, Jin L, Zhang M, Jiang P, Liu F, Meng S, Zhang X, Jiang P, Cao CM, Xiao RP.

Nature. 2013 Feb 21;494(7437):375-9. doi: 10.1038/nature11834. Epub 2013 Jan 27.

PMID:
23354051
[PubMed - indexed for MEDLINE]
20.

New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).

Tjokroprawiro A.

Acta Med Indones. 2006 Jul-Sep;38(3):160-6. Review.

PMID:
17119268
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk